Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients
Authors
Keywords
Prognosis, Immunologic adjuvants, Adjuvant chemotherapy, Pancreatic cancer, Cancer treatment, Hyperexpression techniques, Pancreas, Metastasis
Journal
PLoS One
Volume 14, Issue 6, Pages e0217920
Publisher
Public Library of Science (PLoS)
Online
2019-06-06
DOI
10.1371/journal.pone.0217920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
- (2017) Marianne Sinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin
- (2016) Keisuke Taniuchi et al. CANCER SCIENCE
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
- (2016) Katsuhiko Uesaka et al. LANCET
- Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells
- (2016) Makiko Tsuboi et al. PANCREATOLOGY
- MERAV: a tool for comparing gene expression across human tissues and cell types
- (2015) Yoav D. Shaul et al. NUCLEIC ACIDS RESEARCH
- Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
- (2015) Moh'd Khushman et al. PANCREATOLOGY
- IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer
- (2015) Keisuke Taniuchi et al. Oncotarget
- Multi-institutional Pooled Analysis on Adjuvant Chemoradiation in Pancreatic Cancer
- (2014) Alessio G. Morganti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- KIF20A-Mediated RNA Granule Transport System Promotes the Invasiveness of Pancreatic Cancer Cells
- (2014) Keisuke Taniuchi et al. NEOPLASIA
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular markers associated with outcome and metastasis in human pancreatic cancer
- (2012) Anke Van den Broeck et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Knockdown of the β1 integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis
- (2011) John J. Grzesiak et al. INTERNATIONAL JOURNAL OF CANCER
- CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
- (2010) Yuri Miyazawa et al. CANCER RESEARCH
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
- (2009) Mark P. Callery et al. ANNALS OF SURGICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now